MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Sells 4,351 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 109,390 shares of the healthcare conglomerate's stock after selling 4,351 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s holdings in UnitedHealth Group were worth $55,336,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also bought and sold shares of the company. LRI Investments LLC boosted its holdings in shares of UnitedHealth Group by 0.5% in the 4th quarter. LRI Investments LLC now owns 18,643 shares of the healthcare conglomerate's stock valued at $9,431,000 after buying an additional 85 shares during the last quarter. LRT Capital Management LLC lifted its holdings in UnitedHealth Group by 84.0% during the 4th quarter. LRT Capital Management LLC now owns 3,427 shares of the healthcare conglomerate's stock valued at $1,734,000 after purchasing an additional 1,564 shares during the last quarter. LifePlan Investment Advisors Inc. raised its holdings in UnitedHealth Group by 12.9% in the 4th quarter. LifePlan Investment Advisors Inc. now owns 428 shares of the healthcare conglomerate's stock valued at $217,000 after acquiring an additional 49 shares during the period. Lionshead Wealth Management LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $361,000. Finally, Investment Management Corp of Ontario increased its stake in shares of UnitedHealth Group by 49.3% during the fourth quarter. Investment Management Corp of Ontario now owns 45,553 shares of the healthcare conglomerate's stock worth $23,043,000 after purchasing an additional 15,032 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Down 11.1%

NYSE UNH traded down $34.05 on Thursday, hitting $273.96. The company's stock had a trading volume of 121,312,755 shares, compared to its average volume of 5,582,486. The firm has a market cap of $248.52 billion, a PE ratio of 17.67, a PEG ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 1-year low of $249.12 and a 1-year high of $630.73. The company's 50-day moving average is $478.83 and its 200 day moving average is $517.83. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter last year, the business earned $6.91 earnings per share. As a group, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 3.07%. UnitedHealth Group's dividend payout ratio (DPR) is currently 35.18%.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on UNH. Mizuho boosted their target price on shares of UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Oppenheimer decreased their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a research report on Wednesday. Wells Fargo & Company cut their price target on UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating for the company in a research note on Wednesday. Deutsche Bank Aktiengesellschaft dropped their price target on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research note on Wednesday. Finally, Robert W. Baird reduced their target price on UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating on the stock in a report on Wednesday. Six research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $508.38.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.